| J0897 | Injection, denosumab, 1 mg | 26,640 | $20 | $479.5K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,960 | $100 | $189.6K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 10,920 | $10 | $87.4K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 900 | $70 | $60.4K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 330 | $150 | $47.7K |
| 99212 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a straightforward level of medical decision making,… | 820 | $50 | $37.6K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 500 | $60 | $29.8K |
| 99454 | The provider supplies one or more devices for remote physiologic monitoring that occurs for 16 to 30 days in a 30–day period. | 710 | $40 | $28.4K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 160 | $130 | $20.7K |
| 95250 | In this procedure, interstitial glucose levels are measured at regular intervals via subcutaneously implanted sensors provided by physician or other qualified health care professional's office for a… | 170 | $110 | $18.6K |